BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
9647 results:

  • 1. The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
    van Maaren MC; van Hoeve JC; Korevaar JC; van Hezewijk M; Siemerink EJM; Zeillemaker AM; Klaassen-Dekker A; van Uden DJP; Volders JH; Drossaert CHC; Siesling S;
    Support Care Cancer; 2024 May; 32(5):323. PubMed ID: 38695938
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic Factors Associated with Tumor Recurrence and Overall Survival in Soft Tissue Sarcomas of the Extremities in a Colombian Reference cancer Center.
    Díaz Casas SE; Villacrés JM; Lehmann Mosquera C; García Mora M; Mariño Lozano I; Ángel Aristizábal J; Suarez Rodríguez R; Duarte Torres CA; Sánchez Pedraza R
    Curr Oncol; 2024 Mar; 31(4):1725-1738. PubMed ID: 38668034
    [No Abstract]    [Full Text] [Related]  

  • 3. The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.
    Huang JY; Chen XL; Xie XF; Song L; Chen LP; Lan XF; Bai X; Chen X; Du CW
    Cancer Med; 2024 Apr; 13(8):e7181. PubMed ID: 38659376
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Are depression and poor sleep quality a major problem in Turkish Women receiving chemotherapy for breast cancer?
    Buyuksimsek M; Gulmez A; Pirinci O; Tohumcuoglu M; Kidi MM
    Rev Assoc Med Bras (1992); 2024; 70(3):e20231377. PubMed ID: 38656011
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
    Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
    JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inflammatory breast cancer (IBC) advocacy-Past, present and future!
    Donahue J; Earls J; Fraser V; Mason G; Pirowski H; Stephens P
    Int Rev Cell Mol Biol; 2024; 384():153-164. PubMed ID: 38637097
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Neighborhood Disadvantage and breast cancer-Specific Survival in the US.
    Goel N; Hernandez AE; Mazul A
    JAMA Netw Open; 2024 Apr; 7(4):e247336. PubMed ID: 38635268
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The use of a selective, nontoxic dual-acting peptide for breast cancer patients with brain metastasis.
    Cavaco M; Pérez-Peinado C; Valle J; Silva RDM; Gano L; Correia JDG; Andreu D; Castanho MARB; Neves V
    Biomed Pharmacother; 2024 May; 174():116573. PubMed ID: 38613996
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. treatment Monitoring of a Patient with Synchronous Metastatic Angiosarcoma and breast cancer Using ctDNA.
    Vannas C; Escobar M; Österlund T; Andersson D; Mouhanna P; Soomägi A; Molin C; Wennergren D; Fagman H; Ståhlberg A
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612833
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Amazons in Mali? Women's experiences of breast cancer and gender (re)negotiation.
    Schantz C; Coulibaly A; Faye K; Traoré D;
    Soc Sci Med; 2024 May; 348():116874. PubMed ID: 38608482
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Significance of Estrogen/Progesterone Receptor Expression in Metaplastic breast Carcinoma.
    Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
    Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams.
    Loap P; Giorgi M; Vu-Bezin J; Kirov K; Sampai JM; Prezado Y; Kirova Y
    Cancer Radiother; 2024 Apr; 28(2):195-201. PubMed ID: 38599941
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
    van der Voort A; Louis FM; van Ramshorst MS; Kessels R; Mandjes IA; Kemper I; Agterof MJ; van der Steeg WA; Heijns JB; van Bekkum ML; Siemerink EJ; Kuijer PM; Scholten A; Wesseling J; Vrancken Peeters MTFD; Mann RM; Sonke GS;
    Lancet Oncol; 2024 May; 25(5):603-613. PubMed ID: 38588682
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
    Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
    Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing.
    Muraleedharan A; Barik SK; Das DK; Das Majumdar SK; Mahapatra BR; Barik BK; Ramasubbu MK; M NHK; U PD; Ahmed SS; Mukherjee P; Pattanaik A; Badajena A; Mishra M; Kanungo S; Dhar SS; Parida DK
    J Egypt Natl Canc Inst; 2024 Apr; 36(1):11. PubMed ID: 38584227
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Premastectomy Radiotherapy and Immediate breast Reconstruction: A Randomized Clinical Trial.
    Schaverien MV; Singh P; Smith BD; Qiao W; Akay CL; Bloom ES; Chavez-MacGregor M; Chu CK; Clemens MW; Colen JS; Ehlers RA; Hwang RF; Joyner MM; Largo RD; Mericli AF; Mitchell MP; Shuck JW; Tamirisa N; Tripathy D; Villa MT; Woodward WA; Zacharia R; Kuerer HM; Hoffman KE
    JAMA Netw Open; 2024 Apr; 7(4):e245217. PubMed ID: 38578640
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy.
    Nogi H; Ogiya A; Ishitobi M; Yamauchi C; Mori H; Shimo A; Narui K; Nagura N; Seki H; Sasada S; Sakurai T; Shien T;
    Breast Cancer; 2024 May; 31(3):507-518. PubMed ID: 38573438
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.
    Wang J; Li B; Luo M; Huang J; Zhang K; Zheng S; Zhang S; Zhou J
    Signal Transduct Target Ther; 2024 Apr; 9(1):83. PubMed ID: 38570490
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tucatinib Combination treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic breast cancer.
    Frenel JS; Zeghondy J; Guérin-Charbonnel C; Mailliez A; Volant E; Poumeaud F; Patsouris A; Arnedos M; Bailleux C; Cabal J; Galland L; de Nonneville A; Guiu S; Dalenc F; Pistilli B; Bachelot T; Pierga JY; Le Du F; Bocquet F; Larrouquere L; Loirat D
    JAMA Netw Open; 2024 Apr; 7(4):e244435. PubMed ID: 38568692
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
    Wu Z; Zhang Q; Jin Y; Zhang X; Chen Y; Yang C; Tang X; Jiang H; Wang X; Zhou X; Yu F; Wang B; Guan M
    BMC Cancer; 2024 Apr; 24(1):411. PubMed ID: 38566028
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 483.